Jeffrey C. Sprecher - 23 Feb 2022 Form 4 Insider Report for Intercontinental Exchange, Inc. (ICE)

Role
Chief Executive Officer, Director
Signature
/s/ Octavia N. Spencer, Attorney-in-fact
Issuer symbol
ICE
Transactions as of
23 Feb 2022
Net transactions value
-$8,069,534
Form type
4
Filing time
25 Feb 2022, 15:38:22 UTC
Previous filing
23 Feb 2022
Next filing
27 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ICE Common Stock Options Exercise $2,634,442 +63,680 +4.8% $41.37 1,380,220 23 Feb 2022 Direct F1
transaction ICE Common Stock Options Exercise $99,770 +1,995 +0.14% $50.01 1,382,215 23 Feb 2022 Direct F1
transaction ICE Common Stock Sale $4,355,120 -35,172 -2.5% $123.82 1,347,043 23 Feb 2022 Direct F1, F2
transaction ICE Common Stock Sale $4,232,718 -33,928 -2.5% $124.76 1,313,115 23 Feb 2022 Direct F1, F3
transaction ICE Common Stock Sale $2,215,907 -17,645 -1.3% $125.58 1,295,470 23 Feb 2022 Direct F1, F4, F5
holding ICE Common Stock 3,021,705 23 Feb 2022 CPEX F6
holding ICE Common Stock 81,570 23 Feb 2022 By spouse F7

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ICE Employee Stock Option (right to buy) Holding Options Exercise $0 -63,680 -33% $0.000000 127,360 23 Feb 2022 Common Stock 63,680 $41.37 Direct F8
transaction ICE Employee Stock Option (right to buy) Holding Options Exercise $0 -1,995 -1.1% $0.000000 175,165 23 Feb 2022 Common Stock 1,995 $50.01 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.
F2 The price range for the aggregate amount sold by the direct holder is $123.28 - $124.27. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
F3 The price range for the aggregate amount sold by the direct holder is $124.28 - $125.27. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
F4 The price range for the aggregate amount sold by the direct holder is $125.28 - $126.09. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
F5 The common stock number referred in Table I is an aggregate number and represents 1,235,626 shares of common stock and 59,844 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2022 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023 and will be reported at the time of vesting. The satisfaction of the 2020, 2021 and 2022 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023, February 2024 and February 2025, respectively, and will be reported at the time of vesting.
F6 As previously reported, the reporting person also indirectly owns 3,021,705 shares that are beneficially owned directly by CPEX. The reporting person beneficially owns 100% of the equity interest in CPEX. Additionally, as previously reported, the reporting person indirectly owns shares that are beneficially owned directly by the reporting person's spouse for which the reporting person disclaims beneficial ownership.
F7 As previously reported, the reporting person also indirectly owns 81,570 shares that are beneficially owned directly by the reporting person's spouse for which the reporting person disclaims beneficial ownership.
F8 These options are fully vested.